Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
5 studies found for:    Open Studies | "Lupus Erythematosus, Discoid"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Chronic Cutaneous
Intervention: Drug: Etanercept
2 Unknown † Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
3 Unknown † The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus (DLE)
Intervention: Drug: etanercept(Enbrel®)
4 Recruiting Autologous Polyclonal Tregs for Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Intervention: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
5 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years